middle.news
Control Bionics Moves to Full Ownership of NeuroBounce Program
8:46am on Wednesday 3rd of December, 2025 AEDT
•
Medical Devices
Read Story
Control Bionics Moves to Full Ownership of NeuroBounce Program
8:46am on Wednesday 3rd of December, 2025 AEDT
Key Points
Acquisition of remaining 77.83% of Neuro Elite Athletics for US$389,150
Transaction funded by issuing approximately 7.5 million Control Bionics shares
NeuroBounce program to be integrated with Control Bionics’ NeuroStrip EMG platform
Expansion focus on U.S. and Australian high-growth athletic performance markets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE